Michael E. Placke

650 total citations
19 papers, 510 citations indexed

About

Michael E. Placke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Michael E. Placke has authored 19 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Michael E. Placke's work include Inhalation and Respiratory Drug Delivery (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Michael E. Placke is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Michael E. Placke collaborates with scholars based in United States. Michael E. Placke's co-authors include D. S. Wyand, Steven D. Cohen, A. R. Imondi, David M. Vail, Gary L. Ginsberg, Gerald L. Fisher, Sunil Sharma, Dorothy A. White, Mark G. Kris and Ilene D. Kurzman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Toxicology and Applied Pharmacology.

In The Last Decade

Michael E. Placke

19 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Placke United States 11 213 149 106 103 53 19 510
Lisa A. McConnachie United States 15 36 0.2× 84 0.6× 85 0.8× 207 2.0× 31 0.6× 25 689
Rafael O.P. de Campos United States 13 57 0.3× 107 0.7× 26 0.2× 74 0.7× 68 1.3× 28 547
Lucy Meunier France 13 41 0.2× 101 0.7× 124 1.2× 116 1.1× 89 1.7× 44 546
Madhav Sachar United States 9 83 0.4× 87 0.6× 100 0.9× 143 1.4× 12 0.2× 15 408
Archie Thurston United States 12 60 0.3× 72 0.5× 124 1.2× 166 1.6× 12 0.2× 18 496
Shinji Kobuchi Japan 13 51 0.2× 60 0.4× 198 1.9× 122 1.2× 17 0.3× 61 529
G. Bastian France 12 65 0.3× 33 0.2× 237 2.2× 154 1.5× 21 0.4× 39 403
Zijing Wu China 11 56 0.3× 35 0.2× 47 0.4× 211 2.0× 32 0.6× 28 494
Karel J. Lambert United States 9 109 0.5× 26 0.2× 154 1.5× 119 1.2× 21 0.4× 10 463
Nilay Thakkar United States 9 37 0.2× 47 0.3× 198 1.9× 117 1.1× 45 0.8× 17 467

Countries citing papers authored by Michael E. Placke

Since Specialization
Citations

This map shows the geographic impact of Michael E. Placke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Placke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Placke more than expected).

Fields of papers citing papers by Michael E. Placke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Placke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Placke. The network helps show where Michael E. Placke may publish in the future.

Co-authorship network of co-authors of Michael E. Placke

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Placke. A scholar is included among the top collaborators of Michael E. Placke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Placke. Michael E. Placke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Hong, et al.. (2020). Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist. Regulatory Toxicology and Pharmacology. 112. 104586–104586. 3 indexed citations
2.
Janas, Maja M., Yongfeng Jiang, Ju Liu, et al.. (2016). Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity. Nucleic Acid Therapeutics. 26(6). 363–371. 22 indexed citations
3.
Mulshine, James L., Sung Kyu Hong, Alfredo Martı́nez, et al.. (2001). Moving to the routine management of pre symptomatic lung cancer. Lung Cancer. 34. S1–S5. 1 indexed citations
4.
Sharma, Sunil, Dorothy A. White, A. R. Imondi, et al.. (2001). Development of Inhalational Agents for Oncologic Use. Journal of Clinical Oncology. 19(6). 1839–1847. 82 indexed citations
5.
Mulshine, James L., Luigi M. De Luca, Robert L. Dedrick, et al.. (2000). Considerations in developing successful, population-based molecular screening and prevention of lung cancer. Cancer. 89(S11). 2465–2467. 11 indexed citations
6.
Hershey, Alexander, Ilene D. Kurzman, Lisa J. Forrest, et al.. (1999). Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.. PubMed. 5(9). 2653–9. 88 indexed citations
7.
Placke, Michael E., Larry C. Griffis, Michael G. Bird, et al.. (1996). Chronic inhalation oncogenicity study of isoprene in B6C3F1 mice. Toxicology. 113(1-3). 253–262. 25 indexed citations
8.
Hurtt, Mark E., et al.. (1992). 13-Week Inhalation Toxicity Study of Dimethylformamide (DMF) in Cynomolgus Monkeys. Toxicological Sciences. 18(4). 596–601. 4 indexed citations
9.
Wientjes, M. Guillaume, Michael E. Placke, Ming Chang, et al.. (1991). Pharmacokinetics of 2′,3′-dideoxyadenosine in dogs. Investigational New Drugs. 9(2). 159–168. 9 indexed citations
10.
Hurtt, Mark E., et al.. (1991). Ten-day repeated-exposure inhalation study of dimethylformamide (DMF) in cynomolgus monkeys. Toxicology Letters. 59(1-3). 229–237. 4 indexed citations
11.
Placke, Michael E. & Gerald L. Fisher. (1987). Asbestos Ill Peripheral Lunc Culture a Species Comparison of Pulmonary Tissue Response. Drug and Chemical Toxicology. 10(1-2). 133–156. 6 indexed citations
12.
Placke, Michael E.. (1987). Adult peripheral lung organ culture?A model for respiratory tract toxicology. Toxicology and Applied Pharmacology. 90(2). 284–298. 58 indexed citations
13.
Placke, Michael E., Gary L. Ginsberg, D. S. Wyand, & Steven D. Cohen. (1987). Ultrastructural Changes during Acute Acetaminophen-Induced Hepatotoxicity in the Mouse: A Time and Dose Study. Toxicologic Pathology. 15(4). 431–438. 80 indexed citations
14.
Placke, Michael E., David Hill, & Tao Yang. (1987). Cranial Metastasis of Canine Transmissible Venereal Sarcoma. Journal of Veterinary Medicine Series A. 34(1-10). 125–132. 11 indexed citations
15.
Fisher, Gerald L. & Michael E. Placke. (1987). In vitro models of lung toxicity. Toxicology. 47(1-2). 71–93. 22 indexed citations
16.
Placke, Michael E., D. S. Wyand, & Steven D. Cohen. (1987). Extrahepatic Lesions Induced by Acetaminophen in the Mouse. Toxicologic Pathology. 15(4). 381–387. 65 indexed citations
17.
Placke, Michael E., Min Jung Chang, & G. L. Fisher. (1986). Age-sensitive morphologic changes in tracheal organ culture following carcinogen exposure. Toxicology and Applied Pharmacology. 86(2). 253–261. 2 indexed citations
18.
Placke, Michael E., et al.. (1982). Hepatocellular adenocarcinoma in a white-tailed deer (Odocoileus virginianus).. PubMed. 46(2). 198–200. 3 indexed citations
19.
Ginsberg, Gary L., Michael E. Placke, D. S. Wyand, & Steven D. Cohen. (1982). Protection against acetaminophen-induced hepatotoxicity by prior treatment with fenitrothion. Toxicology and Applied Pharmacology. 66(3). 383–399. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026